Archive

Post Archive: Alex Spira MD PhD FACP

Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Page 2

RESECTABLE NSCLC AND THE IMPORTANCE OF GUIDELINE-RECOMMENDED MOLECULAR TESTING

Lung Cancer Team, Fairfax Office, Fairfax Cancer Center, Thoracic Surgery, Alex Spira MD PhD FACP, Lung Cancer
February 22, 2022
Read More

Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spria, MD, PhD, FACP

Alex Spira MD PhD FACP, GI Cancer
January 20, 2022
Read More

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Mitul Gandhi MD
October 11, 2021
Read More

Next Oncology Expands Phase I Program with Virginia Cancer Specialists Partnership

NEXT Oncology, Alex Spira MD PhD FACP, Clinical Trials and Research
October 6, 2021
Read More

A monumental step forward in the treatment of non-small cell lung cancer patients harboring a KRAS mutation, Dr. Christina Brzezniak

Lung Cancer Team, Christina Brzezniak DO, Alex Spira MD PhD FACP, Lung Cancer, Non-Small Cell Lung Cancer
June 16, 2021
Read More

Alexander I Spira, MD, PhD, FACP - Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

Alex Spira MD PhD FACP, Lung Cancer
June 4, 2021
Read More

Exploring Why Testing in Lung Cancer is Important to Treatment Decisions - Alex Spira, MD, PhD, FACP

Alex Spira MD PhD FACP, Lung Cancer
February 23, 2021
Read More

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Lung Cancer
February 4, 2021
Read More

Interview with Dr. Alex Spira - Medpage Today Lung Cancer and Covid19

Alex Spira MD PhD FACP, Lung Cancer
June 16, 2020
Read More

Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial

Alex Spira MD PhD FACP, Clinical Trials and Research, The Sarcoma Center, Sarcoma
April 9, 2020
Read More
Return to Top